Emerging evidence has revealed that alterations in HIF‐1α, oncogenes, and tumor suppressor genes lead to upregulated expression of GLUTs and key metabolic enzymes of glucose metabolism, thereby increasing the rate of glucose metabolism in various cancer types, including lung, breast, liver, and oral cancer.254, 255. The gene discussed is HIF1A; the disease is cancer.